Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines.
Cell Rep. 2022 Jun 21;39(12):110988. doi: 10.1016/j.celrep.2022.110988.
Cell Rep. 2022.
PMID: 35732123
Free article.
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma.
Li Q, Demir S, Del Río-Álvarez Á, Maxwell R, Wagner A, Carrillo-Reixach J, Armengol C, Vokuhl C, Häberle B, von Schweinitz D, Schmid I, Cairo S, Kappler R.
Li Q, et al. Among authors: carrillo reixach j.
Cancers (Basel). 2022 Aug 30;14(17):4196. doi: 10.3390/cancers14174196.
Cancers (Basel). 2022.
PMID: 36077733
Free PMC article.
Item in Clipboard
LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways.
Mosca N, Khoubai FZ, Fedou S, Carrillo-Reixach J, Caruso S, Del Rio-Alvarez A, Dubois E, Avignon C, Dugot-Senant N, Guettier C, Mussini C, Zucman-Rossi J, Armengol C, Thiébaud P, Veschambre P, Grosset CF.
Mosca N, et al. Among authors: carrillo reixach j.
Liver Cancer. 2021 Dec 21;11(2):126-140. doi: 10.1159/000521595. eCollection 2022 Apr.
Liver Cancer. 2021.
PMID: 35634422
Free PMC article.
Item in Clipboard
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Carrillo-Reixach J, Torrens L, Simon-Coma M, Royo L, Domingo-Sàbat M, Abril-Fornaguera J, Akers N, Sala M, Ragull S, Arnal M, Villalmanzo N, Cairo S, Villanueva A, Kappler R, Garrido M, Guerra L, Sábado C, Guillén G, Mallo M, Piñeyro D, Vázquez-Vitali M, Kuchuk O, Mateos ME, Ramírez G, Santamaría ML, Mozo Y, Soriano A, Grotzer M, Branchereau S, de Andoin NG, López-Ibor B, López-Almaraz R, Salinas JA, Torres B, Hernández F, Uriz JJ, Fabre M, Blanco J, Paris C, Bajčiová V, Laureys G, Masnou H, Clos A, Belendez C, Guettier C, Sumoy L, Planas R, Jordà M, Nonell L, Czauderna P, Morland B, Sia D, Losic B, Buendia MA, Sarrias MR, Llovet JM, Armengol C.
Carrillo-Reixach J, et al.
J Hepatol. 2020 Aug;73(2):328-341. doi: 10.1016/j.jhep.2020.03.025. Epub 2020 Mar 30.
J Hepatol. 2020.
PMID: 32240714
Free article.
Item in Clipboard
A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.
Cairo S, Armengol C, Maibach R, Häberle B, Becker K, Carrillo-Reixach J, Guettier C, Vokuhl C, Schmid I, Buendia MA, Branchereau S, von Schweinitz D, Kappler R.
Cairo S, et al. Among authors: carrillo reixach j.
Eur J Cancer. 2020 Dec;141:30-39. doi: 10.1016/j.ejca.2020.09.026. Epub 2020 Oct 27.
Eur J Cancer. 2020.
PMID: 33125945
Free article.
Item in Clipboard
Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response.
Failli M, Demir S, Del Río-Álvarez Á, Carrillo-Reixach J, Royo L, Domingo-Sàbat M, Childs M, Maibach R, Alaggio R, Czauderna P, Morland B, Branchereau S, Cairo S, Kappler R, Armengol C, di Bernardo D.
Failli M, et al. Among authors: carrillo reixach j.
Hepatology. 2023 Sep 20. doi: 10.1097/HEP.0000000000000601. Online ahead of print.
Hepatology. 2023.
PMID: 37729391
Item in Clipboard
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Abril-Fornaguera J, Torrens L, Andreu-Oller C, Carrillo-Reixach J, Rialdi A, Balaseviciute U, Pinyol R, Montironi C, Haber PK, Del Río-Álvarez Á, Domingo-Sàbat M, Royo L, Akers NK, Willoughby CE, Peix J, Torres-Martin M, Puigvehi M, Cairo S, Childs M, Maibach R, Alaggio R, Czauderna P, Morland B, Losic B, Mazzaferro V, Guccione E, Sia D, Armengol C, Llovet JM.
Abril-Fornaguera J, et al. Among authors: carrillo reixach j.
Mol Cancer Ther. 2023 Apr 3;22(4):485-498. doi: 10.1158/1535-7163.MCT-22-0335.
Mol Cancer Ther. 2023.
PMID: 36780225
Free PMC article.
Item in Clipboard
Cite
Cite